Evidence map›Paper›PMID 21369960›Full record

ArticleInternational journal of clinical pharmacy2011

Prescribing pattern of antihypertensive drugs in a general hospital in central China.

Hong Cheng

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Management of Hypertension in the Asia-Pacific Region: A Structured Review.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2024
    Review
  3. Article
  4. Systolic hypertension: an increasing clinical challenge in Asia.Hypertension research : official journal of the Japanese Society of Hypertension · 2015
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Hong ChengDepartment of Pharmacy, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei Province, China. chenghong6668@yahoo.com.cn
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo examine the prescribing pattern of antihypertensive drugs in outpatients with hypertension in a general hospital in central China and identify whether the pattern of prescribing is appropriate and in accordance with national and international guidelines for pharmacotherapy of hypertension.

settingThe internal medicine department of Zhongnan Hospital in central China.

methodAntihypertensive prescription data were collected from the hospital's central computer database from 1 March 2008 to 31 March 2008.

main outcome measureThe most frequently used antihypertensive medications, as a percentage of treatment and of monotherapy or combination therapy.

results1,206 prescriptions were included in the analysis. The mean age of the patient population was 61.3 ± 13.7 years and 68.6% were male. The mean number of drugs used by the patient was 1.45 ± 0.66. Of the patients, 62.9% were receiving monotherapy, 29.4% two drugs, 6.9% three drugs, and 0.8% four drugs. Most patients were receiving calcium channel blockers (58.0%), followed by angiotensin receptor blockers (34.2%), angiotensin-converting enzyme inhibitors (17.5%), beta-blockers (16.9%) and diuretics (16.7%).

conclusionThis study showed that most outpatients with hypertension in our hospital received monotherapy although national and international guidelines indicated that monotherapy achieves the BP target in only a limited number of hypertensive patients. We also found that the most frequently used class of antihypertensive drugs was calcium channel blockers then angiotensin receptor blockers. Despite the various benefits of diuretics, they remain underutilized. Moreover, calcium channel blockers were used most frequently in hypertensive patients with comorbidities.

Indexed as

AgedAntihypertensive AgentsChinaComorbidityDrug Therapy, CombinationDrug UtilizationFemaleGuideline AdherenceHospitals, GeneralHumansHypertensionMaleMiddle AgedOutpatientsPractice Guidelines as TopicPractice Patterns, Physicians'Antihypertensive Agents

Identifiers

PMID21369960
OpenAlexW1979377885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.